Valuation (38%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -0.66 | -23.37 |
| PEG Ratio (TTM) | 0.03 | -7.10 |
| P/S Ratio (TTM) | 0.84 | 44.34 |
| P/B Ratio (TTM) | 0.32 | 33.03 |
| P/FCF Ratio (TTM) | -0.72 | -7.73 |
| Price to 5YR AVG Earnings Ratio | -0.83 | -7.08 |
| Price to 5YR AVG FCF Ratio | -1.14 | -13.02 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -40.72% | -15.67% |
| ROE (TTM) | -40.87% | 27.44% |
| Net Profit Margin (TTM) | -126.34% | -627.99% |
| ROIC 5YR AVG | -2,066.56% | -4.84% |
Growth (25%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -66.48% | -57.78% | -64.18% |
| Revenue | 152.00% | 1,843.21% | 1,420.60% |
| Net Income | -66.16% | -95.65% | -87.41% |
| Cash Flow | -49.77% | -429.75% | -8,155.79% |
Health (32%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 6.45 | 5.66 |
| Quick Ratio (TTM) | 6.55 | 5.44 |
| D/E Ratio (TTM) | N/A | 1.19 |
| Interest Coverage (TTM) | -24.88 | -5.92 |
| Piotroski F-Score | 2 | 5 |
| Altman Z-Score | N/A | 13.21 |
| LTL to 5YR AVG FCF | -0.02 | 0.09 |
| Shares Outstanding Growth 5YR AVG | 29.32% | 39.51% |